Log in to save to my catalogue

Isolated Amyloid‐β biomarker positivity: Alzheimer's disease in a mixed pathologies context?

Isolated Amyloid‐β biomarker positivity: Alzheimer's disease in a mixed pathologies context?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716624

Isolated Amyloid‐β biomarker positivity: Alzheimer's disease in a mixed pathologies context?

About this item

Full title

Isolated Amyloid‐β biomarker positivity: Alzheimer's disease in a mixed pathologies context?

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (S2), p.n/a

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
The in vivo amyloid‐β (A) and tau (T) biomarkers have been validated against the respective neuropathological burden of amyloid‐β plaques and neurofibrillary tangles. We aimed to assess the impact of mixed pathologies on the interpretation of AT biomarker system.
Method
A subset of 71 ADNI participants with available neuropathol...

Alternative Titles

Full title

Isolated Amyloid‐β biomarker positivity: Alzheimer's disease in a mixed pathologies context?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716624

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716624

Other Identifiers

ISSN

1552-5260

E-ISSN

1552-5279

DOI

10.1002/alz.091213

How to access this item